---
title: "Xeris Biopharma | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 92.1 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295097929.md"
datetime: "2026-08-06T11:17:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295097929.md)
  - [en](https://longbridge.com/en/news/295097929.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295097929.md)
generator: "portal-rs"
---

# Xeris Biopharma | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 92.1 M

Revenue: As of FY2026 Q2, the actual value is USD 92.1 M, beating the estimate of USD 90.13 M.

EPS: As of FY2026 Q2, the actual value is USD -0.18.

EBIT: As of FY2026 Q2, the actual value is USD 10.66 M.

The provided reference is a Form 8-K filing by Xeris Biopharma Holdings, Inc. stating that the company issued a press release on August 6, 2026, which contains information about its results of operations and business highlights for the three and six months ended June 30, 2026. However, the detailed financial metrics, operational metrics, cash flow, unique company-specific indicators, and any forward-looking outlook or guidance from this press release are not included within the provided reference text.

### Related Stocks

- [XERS.US](https://longbridge.com/en/quote/XERS.US.md)

## Related News & Research

- [Xeris Biopharma CFO Steven Pieper disposes of 5,000 shares worth $42,500](https://longbridge.com/en/news/297704175.md)
- [Xeris Biopharma (NASDAQ:XERS) Insider Sells 16,666 Shares](https://longbridge.com/en/news/297706605.md)
- [Igua Sergipe board signs off Q2 2026 financial results](https://longbridge.com/en/news/297932404.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)
- [Quanta Services announces dividend of R$ 0.03 per unit for Q3 2026](https://longbridge.com/en/news/297931955.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**